News

Hikma signs deal with GP Pharma for Lutrate 1 month in MENA region

22-10-2012

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) has signed a license and supply agreement for the…

GenericsGP PharmHikma PharmaceuticalsLicensingLutrateOncologyRest of the World

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region

24-11-2011

Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Hikma expands its manufacturing capabilities in Algeria taking full control of JV; signs biosimilars deal with CellTrion

13-04-2010

Jordanian-owned Hikma Pharmaceuticals says that its wholly-owned subsidiary, Arab Pharmaceutical Manufacturing…

BiotechnologyCellTrionGenericsHikma PharmaceuticalsLicensingMergers & AcquisitionsPharmaceuticalRest of the World

COMPANY SPOTLIGHT

Menarini

Back to top